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Objective: To investigate the effect of Rhinacanthus nasutus (R. nasutus) leaf extract on
impaired glucose and lipid metabolism in obese ICR mice.
Methods: Obesity was induced in the male ICR mice by feeding them a high-fat diet
(60 kcal% fat) for 12 weeks. After the ﬁrst six weeks of the diet, the obese mice were
administered with the water extract of R. nasutus leaves at 250 and 500 mg/kg per day for
the next six weeks. Subsequently, the blood glucose, lipid proﬁles, insulin, leptin, and
adiponectin levels were measured. The liver and adipose tissues were excised for his-
topathological examination and protein expression study.
Results: After six weeks of the treatment, R. nasutus extract (at 250 and 500 mg/kg per
day) was found to reduce the elevated blood glucose level, improve the insulin sensitivity,
decrease the serum leptin, and increase the serum adiponectin levels. The obese mice
treated with R. nasutus were found to have a reduction in the increased lipid concen-
trations in their serum and liver tissues. Moreover, treatment with R. nasutus reduced the
fat accumulation in the liver and the large adipocyte size in the fat tissues. Interestingly,
the administration with R. nasutus extract was marked by an increase in the hepatic
peroxisome proliferators-activated receptor alpha, fat cell adiponectin, and glucose
transporter 4 proteins.
Conclusions: To the best of our knowledge, the present study is the ﬁrst report on the
impact of R. nasutus extract in improving the impaired glucose and lipid metabolism in
high-fat diet-induced obesity in mice via stimulating the insulin sensitivity in the liver and
adipose tissues.1. Introduction
Abnormal lipid metabolism in obesity can impair insulin
signaling by inhibiting the release of glucose from the liver and its
uptake by the fat and muscle cells [1]. An overloaded long-term
high-fat diet (HFD) leads to obesity, which can induce insulin
resistance in many tissues such as the liver, skeletal muscle, and
adipose tissues. In the insulin-resistant state, insulin is unable to
inhibit lipolysis, which results in increased circulating free fattyacid (FFA) [2]. The elevated FFA levels increase the chronic
hyperglycemia and hypertriglyceridemia. Hepatic insulin
resistance can increase the hepatic gluconeogenesis and
lipogenesis [3]. FFA accumulation in the liver results in hepatic
steatosis and contributes towards dysfunctional insulin signaling
[4]. Moreover, the adipose tissues in the obese state are largely
expanded and function abnormally in the regulation of cytokine
release as well as fatty acid metabolism and its storage [4].
Insulin is themost important hormone for the regulationofblood
glucose level. Glucose transport, the rate-limiting step in carbohy-
drate metabolism, is facilitated by glucose transporters (GLUT)
across the cell membranes. GLUT4, a major GLUT, stimulates
glucose uptake into fat and muscle cells. Its function is crucial for
the condition of insulin sensitivity [5]. It has been reported that the
overexpression of GLUT4 gene reduces the hyperglycemic and
hyperinsulinemic conditions in HFD-fed transgenic mice [6].
Adiponectin is an adipokine secreted by the adipose tissues thatan open access article under the CC BY-NC-ND
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proliferators-activated receptor alpha (PPARa) plays an impor-
tant role in the regulation of lipid metabolism in the liver. PPARa
enhances the uptake, utilization, and catabolismof the fatty acids by
up-regulating the genes, which are involved in the transport,
binding, and b-oxidation of fatty acids [8]. It has been shown that
PPARa agonist improves hepatic and muscle insulin resistance,
decreases hepatic and intramuscular fat content, decreases plasma
FFA, and enhances adiponectin expression in rodents [9–13].
Rhinacanthus nasutus (R. nasutus) is found naturally in In-
dia, South China, and Southeast Asia including Thailand.
R. nasutus has been reported to have several bioactivities such as
anti-allergic [14], neuroprotective [15], antidiabetic [16], antitumor
[17], and neuroprotective activities [18]. However, the effects of
the water extract of R. nasutus leaves on obesity have not
been clearly demonstrated yet. Therefore, given the increasing
incidence of obesity, the aim of this study was to investigate
the effect of the extract of R. nasutus on impaired glucose and
lipid metabolism in HFD-fed mice.2. Materials and methods
2.1. Plant extraction
Leaves of R. nasutus were collected from Buriram, Thailand,
between July and September 2014. A voucher herbarium specimen
(SKP 001 18 14 01) was given by the Faculty of Pharmaceutical
Sciences, Prince of Songkla University, Thailand. The dried leaves
were extractedwithwater at 100 Cfor 30min. The extractwas then
concentrated and freeze-dried. After this procedure, the yield was
25.11% of the initial dry weight of the leaves. The obtained
R. nasutus extract was kept at −20 C until it was further used. The
amount of the total polyphenol and ﬂavonoid were calculated to be
(91.10 ± 0.97) mg gallic acid equivalents per gram of extract and
(85.65 ± 0.40) mg catechin/g extract, respectively. The prior was
determinedbyFolin-Ciocalteumethod [19],while the laterwas from
the method derived by Sumczynski et al. [20].
2.2. Animals, diets, and obesity induction
All animal experiment protocols were approved by the Animal
Care andUseCommittee of Thammasat University, PathumThani,
Thailand (Record No. AE 006/2014). Thirty-two male ICR mice
weighing 2025 g were obtained from the National Laboratory
Animal Center of Mahidol University, Nakhon Pathom, Thailand.
They were maintained in an air-conditioned room [(25 ± 2) C] at a
12 h light/12 h dark cycle and fed with normal diet and water ad
libitum for a week. After random selection, the mice were fed with
normal diet (Research Diets, New Brunswick, NJ, USA) contain-
ing 10% of energy as fat (cholesterol in lard was 0.72 mg/g), 70%
as carbohydrate, and 20% as protein (total energy was 3.85 kcal/g)
or HFD (Research Diets, New Brunswick, NJ, USA) containing
60% as fat (cholesterol in lard was 0.72 mg/g), 20% as carbohy-
drate, and 20% as protein (total energy was 5.24 kcal/g) for 12
weeks. After the ﬁrst six weeks of HFD, the obesity condition was
observed.
2.3. Experimental study
The obese animals were weighed and randomly divided into
three groups with eight mice per group and were orally treated asfollows: obese control mice (OB) treated with 5% gum arabic,
obese mice treated with R. nasutus 250 mg/kg per day, and
obese mice treated with R. nasutus 500 mg/kg per day. In the
normal control group (NC), the mice were also treated with 5%
gum arabic. All mice were administered for six weeks. Gum
arabic at 5% concentration was used for dissolving R. nasutus
extract. The doses of the extract were selected based on the
preliminary test. We also studied an acute toxicity test and found
that the R. nasutus water extract did not show any toxicity in
mice at the doses of 250, 500, 1000, and 2000 mg/kg for a week
(data have not been shown). Changes in the body weight, food
consumption, and caloric intake were monitored weekly. After
six weeks of treatment, mice were fasted for 6 h and anesthetized
with isoﬂurane. Blood samples were collected from the hearts of
all mice to determine their blood glucose, lipid proﬁle, insulin,
leptin, and adiponectin levels. After the blood collection, the
liver and epididymal fat tissues were removed from the mice and
subjected to histological examinations. The rest of these tissues
were stored at −80 C until analysis.
2.4. Intraperitoneal glucose tolerance test (IPGTT)
After ﬁve weeks of treatment, an IPGTT was performed on
the mice to evaluate the effect of each treatment on their glucose
tolerance. After 6 h of fasting, the mice were injected with
glucose (2 g/kg), followed by the collection of blood samples
from the tail vein at 0, 20, 60, and 120 min.
2.5. Measurement of serum insulin, leptin and
adiponectin levels
After six weeks of treatment, the serum insulin, leptin, and
adiponectin concentrations in mice at fasting condition were
measured by using ELISA kit (EMD Millipore, Billerica, MA,
USA). The index of the homeostasis model assessment of in-
sulin resistance (HOMA-IR) was calculated as an indicator of
insulin sensitivity according to the following formula: [insulin
(mIU) × glucose (mmol/L)]/22.5.
2.6. Measurement of serum and liver lipid proﬁles
After six weeks of treatment, serum total cholesterol (TC),
triglyceride (TG), and non-esteriﬁed fatty acid (NEFA) con-
centrations were determined by using commercial kits (Wako,
Osaka, Japan).
For determination of liver TG and NEFA accumulations,
100 mg of the liver was used to extract lipids according to the
previous study [21]. TG and NEFA concentrations were
measured by using commercial kits (Wako, Osaka, Japan).
2.7. Western immunoblotting
Liver and epididymal fat tissues were homogenized and
extracted with TPER® and Halt® protease inhibitor (Thermo
Scientiﬁc, Rockford, IL, USA). For Western blot analysis, 40 mg
of liver PPARa and 20 mg of fat cell adiponectin and GLUT4
proteins were separated by 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and transferred to a poly-
vinylidene ﬂuoride membrane. The membrane was blocked with
5% skimmed milk in Tris-buffered saline containing 0.01%
Tween 20 for 1 h. The blocked membrane was incubated
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anti-actin primary antibodies (Santa Cruz Biotechnology, Dallas,
TX, USA) at 4 C. After incubation with horseradish
peroxidase-conjugated secondary antibody for 2 h at room
temperature, the immunoreactive proteins were developed and
the intensities of each band were quantiﬁed by densitometry
with an ImageQuant™ 400 imager (GE Healthcare Life Sci-
ences, Piscataway, NJ, USA). Actin was used as a loading
control to normalize the target proteins.
2.8. Histopathology
Liver and epididymal fat tissues were ﬁxed in 10% formalin
and embedded in parafﬁn. Three-micron sections were cut and
stained with hematoxylin and eosin for examination of the liver
and adipose tissue histology (CX31; Olympus, Tokyo, Japan).
The fat cell size was calculated by using an Image J Software
program (National Institute of Health, Bethesda, MD, USA).
2.9. Statistical analyses
Data were expressed as the mean ± SEM. The groups of data
were compared by One-way ANOVA followed by the Tukey's
post hoc test (SigmaStat Software, CA, USA). Statistical ana-
lyses with the P value less than 0.05 were considered
signiﬁcant.NC
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3.1. Effect of R. nasutus on metabolic abnormalities in
HFD-induced obese mice
After six weeks of induced obesity, the body weight was found
to be signiﬁcantly higher in the OB group compared to the NC
group (Figure 1A). However, the body weight of OB mice treated
with either 250 or 500 mg/kg R. nasutus did not show any signiﬁ-
cant decrease in comparison to the OB group. No signiﬁcant dif-
ferencewas observed in food intake among the groups (Figure 1B).
However, all of the OB groups showed a signiﬁcant increase in the
energy intake compared to the NC group (Figure 1C).
The OB group signiﬁcantly increased the epididymal fat weight
compared to the NC group (Figure 2A). Interestingly, the obese
mice treated with both 250 and 500mg/kgR. nasutus demonstrated
the reduction in the body fat. Moreover, their enlarged fat cell size
signiﬁcantly decreased compared to the OB group (Figure 2B,C).
After six weeks of R. nasutus (250 and 500 mg/kg) treatment,
the fasting blood glucose was signiﬁcantly reduced compared to
the OB group (Figure 3A). The administration of R. nasutus
(250 and 500 mg/kg) showed a signiﬁcant reduction in the
elevated insulin level too (Figure 3B). The reduced fasting blood
glucose and insulin levels in the obese mice treated with 250 and
500 mg/kg R. nasutus were found to be effective in decreasing
the index of HOMA-IR (Figure 3C). The serum leptin level wasC
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but it reduced signiﬁcantly after being treated with 250 and
500 mg/kg R. nasutus (Figure 3D). After six weeks of treatment
with R. nasutus, the serum adiponectin levels were signiﬁcantly
higher than that of the obese control mice group (Figure 3E).
After glucose injection, the blood glucose level of the obese
control groupwas signiﬁcantly increased compared to theNCgroup
(Figure 3F). However, the obese mice treated with R. nasutus (250
and 500 mg/kg) showed a signiﬁcant reduction in the high blood
glucose levels at 20, 60, and 120 min compared to the OB group.
After six weeks of treatment, the R. nasutus (250 and 500 mg/
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group, the groups treated with R. nasutus showed a signiﬁcant
reduction in the serum TG and NEFA levels (Figure 4B,C). The
weight of the liver of the OB group increased compared to the
NC group, but the obese mice treated with R. nasutus recorded a
decrease in the weight of their livers (Figure 4D). Moreover, the
storage of hepatic TG and NEFA were signiﬁcantly reduced by
R. nasutus treatment (Figure 4E,F). The accumulation of lipid
droplets in the liver tissue was related to the results of hepatic TG
and NEFA content. The OB group clearly showed increased
hepatic fat accumulation, but its treatment with R. nasutus
markedly reduced the fat accumulation (Figure 4G).B       250       500
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GLUT4 protein expressions
The OB group showed a signiﬁcant reduction in hepatic
PPARa, fat cell adiponectin, and fat cell GLUT4 proteins
expression as compared with the NC group (Figure 5A,B and C,
respectively). Interestingly, R. nasutus strongly reversed the
decreased protein expressions of PPARa, adiponectin, and
GLUT4.2.0
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To the best of our knowledge, the present study is the ﬁrst to
demonstrate the effect of R. nasutus on impaired glucose and
lipid metabolism in the HFD-induced obese mice. Our ﬁndings
stated that HFD can produce a hyperglycemic condition with
decreased glucose tolerance and insulin sensitivity, and
increased insulin and leptin levels in obese mice. This HFD-
induced obesity model also showed an increase in the serum
TC, TG, and NEFA levels, which were similar to those in the
case of human obesity. Furthermore, the HFD-fed mice showed
a large amount of lipid accumulation and increased TG and
NEFA levels in the liver tissue.
The weight of the body and visceral adipose tissue of the
HFD-fed mice (60% kcal fat) was more than that of the mice fed
with a low-fat diet [22,23]. From our study, we found that the
HFD-fed mice also showed a signiﬁcant increase in the
epididymal fat weight. However, the R. nasutus treatment
slightly reduced the body weight, epididymal fat weight, and the
amount of food intake of the obese mice. The energy intake was,
yet, signiﬁcantly higher in HFD mice groups.
The feeding of HFD increased the cholesterol levels via an
increase in the cholesterol absorption by the small intestine [24].
The hypertriglyceridemia observed in the HFD model may be
due to the increased absorption and formation of TG, and
decreased TG uptake by the fat tissues [25]. Many studies have
reported that the elevated fat storage in the liver tissue and the
abnormal circulating FFA are also associated with the
increased insulin resistance [26–28]. Noticeably, all doses of
R. nasutus treatment strongly decreased the hepatic serum TG
and NEFA levels by decreasing the hepatic fat accumulation
in the histological examination.
PPARa is the master regulator of lipid metabolism [29].
PPARa agonists stimulate lipid oxidation, decrease the levelsof circulating TG, increase high-density lipoprotein choles-
terol, and exhibit anti-atherosclerotic activity [30,31]. In our
studies, we found that R. nasutus can reduce the high levels of
serum lipid proﬁles and hepatic fat accumulation. Therefore,
the effect of R. nasutus on the expression of PPARa protein is
an interesting aspect to investigate. After six weeks of
R. nasutus treatment, the protein expression of PPARa
signiﬁcantly improved compared to the obese control mice.
This may lead to the possibility of an improvement in theimpaired lipid metabolism by inhibiting the serum lipid
proﬁles, liver fat accumulation, and stimulating the PPARa
expression through R. nasutus treatment.
Either deﬁciency of insulin or insulin-resistant condition can
induce the dysfunction of GLUT4 resulting in its retention inside
the cell. This dysfunction causes a reduction in the glucose
uptake into the muscle and adipose tissues leading to the in-
crease in the blood glucose levels. These reduction and retention
may be the reason for causing the obese state [6]. In our study,
the HFD-fed mice showed elevated blood glucose, increased
serum insulin levels, and increased HOMA-IR values. Interest-
ingly, the OB mice treated with R. nasutus can improve the
insulin sensitivity by reducing the levels of high blood glucose,
insulin, and HOMA-IR. Restoration of GLUT4 levels would be
helpful in controlling the hyperglycemic and hyperinsulinemic
conditions via an enhancing glucose uptake by the fat tissues.
The present study also showed how the small adipocyte in the
R. nasutus-treated groups could help in increasing the GLUT4
protein expression. These results indicated that R. nasutus may
be stimulating insulin sensitivity in adipose tissues.
Leptin is an adipokine related to the impaired insulin sensi-
tivity condition. It has been reported that leptin is more likely to
be increased in the obesity state [32,33]. In our study, the OB mice
showed an increase in the serum leptin levels, but the levels were
reduced after six weeks of R. nasutus treatment. Adiponectin has
an effect on glucose homeostasis. The circulating level of
adiponectin correlates with insulin sensitivity both in the
humans and rodents [34–36], and it is found to be reduced in
humans with obesity and type 2 diabetes [37]. The induction of
adipose tissue adiponectin expression and consequently, the
increase in circulating adiponectin levels could represent a
novel potential enhancement of whole-body insulin sensitivity
[38]. After the obese mice had been treated with R. nasutus for six
weeks, we found that the levels of serum adiponectin and protein
Supaporn Wannasiri et al./Asian Pac J Trop Biomed 2016; 6(1): 1–76expression levels increased signiﬁcantly. Thus, the treatment with
R. nasutus may cause an increase in the peripheral insulin
sensitivity in the obesity-induced insulin resistant condition.
In conclusion, R. nasutus administration has an impressive
effect on the glucose and lipid metabolism in HFD-induced
obese mice. The effects are as follows: (a) reduction of serum
TG and NEFA levels and lipid accumulation in the liver, (b)
reduction of blood glucose and improvement of insulin sensi-
tivity, and (c) increase of small adipocyte numbers in fat tissue.
Furthermore, R. nasutus may mediate these effects via its posi-
tive effect in stimulating hepatic PPARa, fat adiponectin, and fat
GLUT4 protein expressions. Thus, to the best of our knowledge,
our ﬁndings are the ﬁrst to support the usefulness of R. nasutus
in regulating the abnormalities of glucose and fat metabolism in
HFD-induced obesity condition.
Conﬂict of interest statement
We declare that we have no conﬂict of interest.
Acknowledgments
This research was supported by the research grant from the
Faculty of Medicine, Thammasat University (Contract number:
GEN2-05/2015).
References
[1] Snel M, Jonker JT, Schoones J, Lamb H, de Roos A, Pijl H, et al.
Ectopic fat and insulin resistance: pathophysiology and effect of
diet and lifestyle interventions. Int J Endocrinol 2012; http://
dx.doi.org/10.1155/2012/983814.
[2] Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin
resistance: time for a reevaluation. Diabetes 2011; 60: 2441-9.
[3] Perry RJ, Samuel VT, Petersen KF, Shulman GI. The role of he-
patic lipids in hepatic insulin resistance and type 2 diabetes. Nature
2014; 510: 84-91.
[4] McArdle MA, Finucane OM, Connaughton RM, McMorrow AM,
Roche HM. Mechanisms of obesity-induced inﬂammation and in-
sulin resistance: insights into the emerging role of nutritional
strategies. Front Endocrinol (Lausanne) 2013; 4: 52.
[5] Govers R. Cellular regulation of glucose uptake by glucose trans-
porter GLUT4. Adv Clin Chem 2014; 66: 173-240.
[6] Atkinson BJ, Griesel BA, King CD, Josey MA, Olson AL. Mod-
erate GLUT4 overexpression improves insulin sensitivity and
fasting triglyceridemia in high-fat diet-fed transgenic mice. Dia-
betes 2013; 62: 2249-58.
[7] Lee B, Shao J. Adiponectin and energy homeostasis. Rev Endocr
Metab Disord 2014; 15: 149-56.
[8] Pawlak M, Lefebvre P, Staels B. Molecular mechanism of
PPARalpha action and its impact on lipid metabolism, inﬂamma-
tion and ﬁbrosis in non-alcoholic fatty liver disease. J Hepatol
2015; 62: 720-33.
[9] Ye JM, Iglesias MA, Watson DG, Ellis B, Wood L, Jensen PB,
et al. PPARalpha/gamma ragaglitazar eliminates fatty liver and
enhances insulin action in fat-fed rats in the absence of hepato-
megaly. Am J Physiol Endocrinol Metab 2003; 284: E531-40.
[10] Ye JM, Doyle PJ, Iglesias MA, Watson DG, Cooney GJ,
Kraegen EW. Peroxisome proliferator-activated receptor (PPAR)-
alpha activation lowers muscle lipids and improves insulin sensi-
tivity in high fat-fed rats: comparison with PPAR-gamma activa-
tion. Diabetes 2001; 50: 411-7.
[11] Kim H, Haluzik M, Asghar Z, Yau D, Joseph JW, Fernandez AM,
et al. Peroxisome proliferator-activated receptor-alpha agonist
treatment in a transgenic model of type 2 diabetes reverses the
lipotoxic state and improves glucose homeostasis. Diabetes 2003;
52: 1770-8.[12] Guerre-Millo M, Gervois P, Raspe E, Madsen L, Poulain P,
Derudas B, et al. Peroxisome proliferator-activated receptor alpha
activators improve insulin sensitivity and reduce adiposity. J Biol
Chem 2000; 275: 16638-42.
[13] Choi KC, Ryu OH, Lee KW, Kim HY, Seo JA, Kim SG, et al.
Effect of PPAR-alpha and -gamma agonist on the expression of
visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Biochem Biophys Res Commun 2005; 336: 747-53.
[14] Tewtrakul S, Tansakul P, Panichayupakaranant P. Anti-allergic
principles of Rhinacanthus nasutus leaves. Phytomedicine 2009;
16: 929-34.
[15] Brimson JM, Brimson SJ, Brimson CA, Rakkhitawatthana V,
Tencomnao T. Rhinacanthus nasutus extracts prevent glutamate
and amyloid-beta neurotoxicity in HT-22 mouse hippocampal
cells: possible active compounds include lupeol, stigmasterol and
beta-sitosterol. Int J Mol Sci 2012; 13: 5074-97.
[16] Visweswara Rao P, Madhavi K, Dhananjaya Naidu M, Gan SH.
Rhinacanthus nasutus ameliorates cytosolic and mitochondrial
enzyme levels in streptozotocin-induced diabetic rats. Evid Based
Complement Altern Med 2013; http://dx.doi.org/10.1155/2013/
486047.
[17] Siripong P, Yahuafai J, Shimizu K, Ichikawa K, Yonezawa S,
Asai T, et al. Antitumor activity of liposomal naphthoquinone es-
ters isolated from Thai medicinal plant: Rhinacanthus nasutus
KURZ. Biol Pharm Bull 2006; 29: 2279-83.
[18] Brimson JM, Tencomnao T. Rhinacanthus nasutus protects
cultured neuronal cells against hypoxia induced cell death. Mole-
cules 2011; 16: 6322-38.
[19] Gonzalez de Mejia E, Song YS, Ramirez-Mares MV, Kobayashi H.
Effect of yerba mate (Ilex paraguariensis) tea on topoisomerase
inhibition and oral carcinoma cell proliferation. J Agric Food Chem
2005; 53: 1966-73.
[20] Sumczynski D, Bubelova Z, Sneyd J, Erb-Weber S, Mlcek J. Total
phenolics, ﬂavonoids, antioxidant activity, crude ﬁbre and di-
gestibility in non-traditional wheat ﬂakes and muesli. Food Chem
2015; 174: 319-25.
[21] Naowaboot J, Somparn N, Saentaweesuk S, Pannangpetch P.
Umbelliferone improves an impaired glucose and lipid metabolism
in high-fat diet/streptozotocin-induced type 2 diabetic rats. Phyt-
other Res 2015; 29: 1388-95.
[22] Lim E, Lim JY, Shin JH, Seok PR, Jung S, Yoo SH, et al. D-
Xylose suppresses adipogenesis and regulates lipid metabolism
genes in high-fat diet-induced obese mice. Nutr Res 2015; 35: 626-
36.
[23] Rong X, Li Y, Ebihara K, Zhao M, Naowaboot J, Kusakabe T,
et al. Angiotensin II type 1 receptor-independent beneﬁcial effects
of telmisartan on dietary-induced obesity, insulin resistance and
fatty liver in mice. Diabetologia 2010; 53: 1727-31.
[24] Chandak PG, Obrowsky S, Radovic B, Doddapattar P, Aﬂaki E,
Kratzer A, et al. Lack of acyl-CoA: diacylglycerol acyltransferase 1
reduces intestinal cholesterol absorption and attenuates athero-
sclerosis in apolipoprotein E knockout mice. Biochim Biophys Acta
2011; 1811: 1011-20.
[25] Khalifeh-Soltani A, McKleroy W, Sakuma S, Cheung YY, Tharp K,
Qiu Y, et al. Mfge8 promotes obesity by mediating the uptake of
dietary fats and serum fatty acids. Nat Med 2014; 20: 175-83.
[26] Bermudez JA, Velasquez CM. [Proﬁle of free fatty acids (FFA) in
serum of young Colombians with obesity and metabolic syn-
drome]. Arch Latinoam Nutr 2014; 64: 248-57. Spanish.
[27] Yu X, Ye L, Zhang H, Zhao J, Wang G, Guo C, et al. Ginsenoside
Rb1 ameliorates liver fat accumulation by upregulating perilipin
expression in adipose tissue of db/db obese mice. J Ginseng Res
2015; 39: 199-205.
[28] Neuman MG, Cohen LB, Nanau RM. Biomarkers in nonalcoholic
fatty liver disease. Can J Gastroenterol Hepatol 2014; 28: 607-18.
[29] Shimizu M, Tanaka T, Moriwaki H. Obesity and hepatocellular car-
cinoma: targeting obesity-related inﬂammation for chemoprevention
of liver carcinogenesis. Semin Immunopathol 2013; 35: 191-202.
[30] Gai YT, Shu Q, Chen CX, Lai YL, Li WJ, Peng L, et al. [Anti-
atherosclerosis role of N-oleoylethanolamine in CB2]. Yao Xue Xue
Bao 2014; 49: 316-21. Chinese.
Supaporn Wannasiri et al./Asian Pac J Trop Biomed 2016; 6(1): 1–7 7[31] Li L, Li L, Chen L, Lin X, Xu Y, Ren J, et al. Effect of oleoyle-
thanolamide on diet-induced nonalcoholic fatty liver in rats.
J Pharmacol Sci 2015; 127: 244-50.
[32] Nascimento AF, Luvizotto RA, Leopoldo AS, Lima-Leopoldo AP,
Seiva FR, Justulin LA Jr, et al. Long-term high-fat diet-induced
obesity decreases the cardiac leptin receptor without apparent lip-
otoxicity. Life Sci 2011; 88: 1031-8.
[33] Carvalho KM, Marinho Filho JD, de Melo TS, Araujo AJ, Quetz
Jda S, da Cunha Mdo P, et al. The resin from Protium hepta-
phyllum prevents high-fat diet-induced obesity in mice: scientiﬁc
evidence and potential mechanisms. Evid Based Complement
Altern Med 2015; http://dx.doi.org/10.1155/2015/106157.
[34] Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K,
Miyagawa J, et al. Paradoxical decrease of an adipose-speciﬁcprotein, adiponectin, in obesity. Biochem Biophys Res Commun
1999; 257: 79-83.
[35] Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors.
Endocr Rev 2005; 26: 439-51.
[36] Pajvani UB, Scherer PE. Adiponectin: systemic contributor to in-
sulin sensitivity. Curr Diab Rep 2003; 3: 207-13.
[37] Kim AY, Park YJ, Pan X, Shin KC, Kwak SH, Bassas AF, et al.
Obesity-induced DNA hypermethylation of the adiponectin gene
mediates insulin resistance. Nat Commun 2015; 6: 7585.
[38] Tozzo E, Bhat G, Cheon K, Camacho RC. Pioglitazone increases
whole body insulin sensitivity in obese, insulin-resistant rhesus
monkeys. PloS One 2015; 10: e0126642.
